Breakup Or Bust: Can Pfizer Stand Alone?
August 04, 2016 at 12:35 PM EDT
Five years ago after Pfizer ( PFE ) said it would study the possibility of a breaking up , the drug maker is downplaying the possibility. Pfizer says it will make a decision by year end. In the meantime, what’s an investor to do? Credit Suisse analyst Vamil Divan says that the focus now rests on upside drivers for Pfizer as a standalone company.